MarketBeat listed Vertex, Alnylam, Regeneron, Amgen, Danaher, TG Therapeutics, and Gilead Sciences as stocks to watch.

The entities involved

• MarketBeat →

  American personal finance blog

  • Cantor Fitzgerald restated an overweight rating for MoonLake Immunotherapeutics, which trades on Nasdaq, with data provided by MarketBeat.04:27
  • MarketBeat has provided analyst ratings and targets for two large-cap materials companies: Vulcan Materials Company and Heidelberg Materials.03:37
• Vertex Pharmaceuticals →

  American pharmaceutical company

  • Multiple financial firms, including Americana Partners and Summit Global Investments, adjusted their holdings in Vertex Pharmaceuticals on November 4, 2026.Wed 12:13
  • Royal Bank of Canada raised its price objective for Vertex Pharmaceuticals, with Benzinga and MarketBeat reporting related analyst changes.Tue 17:13
• Amgen →

  American multinational biopharmaceutical company

  • Morgan Stanley and Citigroup raised price objectives on Amgen shares, with MarketBeat reporting the consensus rating.Wed 23:05
  • Amgen, Vertex, and Incyte shares traded on Nasdaq, and Robert A. Bradway leads Amgen's long-term growth strategy.Wed 22:56

Related events

• MarketBeat highlighted Boeing, SpaceX, and Rocket Lab as stocks to watch on October 5, 2026.Oct 6
• MarketBeat listed Teledyne e2v, Digital Turbine, Prologis, and Hamilton Lane as growth stocks to watch on June 7, 2026.Jun 10
• MarketBeat listed Eli Lilly and Company among stocks to watch on October 31, 2026.Sat 18:12
• BioPharma stock was traded on the NASDAQ stock exchange on July 30, 2026, with its performance tracked by financial blogs.Jul 31
• MarketBeat's stock screener highlighted TNL Mediagene.Sat 19:36